VCAM1 and Miyoshi myopathy: Using a MM/BMSC co-culture model to mimic the bone marrow microenvironment, both MPT0G413 and bortezomib inhibited the adherence of MM cells to BMSC (Figure 5A), while combination treatment further enhanced this effect by blocking the connection between VLA4 and VCAM-1.